@article{6d2c896bd245499ba57fa0d9f7563675,
title = "Discontinuation of Superolateral Medial Forebrain Bundle Deep Brain Stimulation for Treatment-Resistant Depression Leads to Critical Relapse",
author = "Kilian, \{Hannah M.\} and Meyer, \{Dora M.\} and Bewernick, \{Bettina H.\} and Susanne Spanier and Coenen, \{Volker A.\} and Schlaepfer, \{Thomas E.\}",
note = "Funding Information: The observations reported in this work have been made in the frame of two studies on effects of DBS in major depression partly funded (DBS devices, battery exchange, medical costs, and limited support for study nurse) by Medtronic Inc., Minneapolis, MN (to TS and VC), and by internal grants from the Universities of Freiburg and Bonn. We thank the patients for their motivation and trust. The authors report no other biomedical financial interests or potential conflicts of interest. ClinicalTrials.gov: Deep Brain Stimulation of the Superolateral Branch of the Medial Forebrain Bundle (slMFB) for the Treatment of Refractory Major Depression (FORESEEII); https://clinicaltrials.gov/ct2/show/NCT01778790; NCT01778790; Effects of Deep Brain Stimulation in Treatment-Resistant Major Depression (FORESEE); https://clinicaltrials.gov/ct2/show/NCT01095263; NCT01095263.",
year = "2019",
month = mar,
day = "15",
doi = "10.1016/j.biopsych.2018.07.025",
language = "English (US)",
volume = "85",
pages = "e23--e24",
journal = "Biological psychiatry",
issn = "0006-3223",
publisher = "Elsevier Inc.",
number = "6",
}